GNMSF vs VRTX: Which Stock is Better?
Side-by-side comparison of Genmab A/S and Vertex Pharmaceuticals Inc in 2026
GNMSF
Genmab A/S
$330.37
VRTX
Vertex Pharmaceuticals Inc
$442.08
Key Metrics Comparison
| Metric | GNMSF | VRTX | Winner |
|---|---|---|---|
| Market Cap | $20.35B | $113.16B | VRTX |
| P/E Ratio | 14.47 | 31.06 | GNMSF |
| EPS (TTM) | $22.83 | $14.21 | GNMSF |
| Revenue Growth | 0.2% | 0.1% | GNMSF |
| Gross Margin | 94.4% | 52.7% | GNMSF |
Analyze GNMSF
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GNMSF or VRTX a better investment?
Comparing GNMSF and VRTX: Genmab A/S has a market cap of $20.35B while Vertex Pharmaceuticals Inc has $113.16B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GNMSF and VRTX?
GNMSF (Genmab A/S) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GNMSF or VRTX?
Based on P/E ratios, GNMSF trades at a lower multiple (14.5x vs 31.1x).
Which is growing faster: GNMSF or VRTX?
GNMSF has higher revenue growth at 0.2% vs 0.1% for VRTX.
Which company is more profitable: GNMSF or VRTX?
Genmab A/S (GNMSF) has higher gross margins at 94.4% compared to 52.7% for VRTX.
Which is the larger company: GNMSF or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.16B compared to $20.35B for GNMSF.
Should I buy GNMSF or VRTX in 2026?
Both GNMSF and VRTX have investment merit. GNMSF trades at $330.37 while VRTX trades at $442.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GNMSF and VRTX stock?
Key differences: Market Cap ($20.35B vs $113.16B), P/E Ratio (14.5x vs 31.1x), Revenue Growth (0.2% vs 0.1%), Gross Margin (94.4% vs 52.7%).